Gilead Sciences director Kelly A. Kramer reports sale of $1.76 million in common shares
GILD•Kelly A. Kramer sold 10,376 Gilead Sciences shares on Nov. 12, 2026, at reported prices of $168.2255–$171.44, and exercised options for 10,376 shares at $66.92 each.




